Novartis Loses Fight With USPTO To Extend 19 Patents

A Washington federal judge on Thursday nixed Novartis AG's bid to extend the life on 19 of its patents, ruling the drugmaker waited too long before challenging the U.S. Patent and...

Already a subscriber? Click here to view full article